Retrospective SARS- CoV-2 human antibody development trajectories are largely sparse and permissive
Journal Article
Overview
publication date
- January 24, 2025
has subject area
- Antigen-Antibody Reactions - Antibody Affinity
- Blood Proteins - Antibodies, Neutralizing
- Blood Proteins - Antibodies, Viral
- Coronavirus Infections - COVID-19
- Environment and Public Health - Retrospective Studies
- Environment and Public Health - Retrospective Studies
- Globulins - Antibodies, Neutralizing
- Globulins - Antibodies, Viral
- Health Care Evaluation Mechanisms - Retrospective Studies
- Health Care Evaluation Mechanisms - Retrospective Studies
- Humans
- Immune System Phenomena - Antibody Affinity
- Immunoproteins - Antibodies, Neutralizing
- Immunoproteins - Antibodies, Viral
- Infections - COVID-19
- Infections - COVID-19
- Investigative Techniques - Retrospective Studies
- Investigative Techniques - Retrospective Studies
- Lung Diseases - COVID-19
- Lymphatic System - Germinal Center
- Membrane Fusion Proteins - Spike Glycoprotein, Coronavirus
- Mutation
- Respiratory Tract Diseases - COVID-19
- Respiratory Tract Diseases - COVID-19
- SARS-CoV-2
- Tissues - Germinal Center
- Viral Structural Proteins - Spike Glycoprotein, Coronavirus
- Virus Diseases - COVID-19
has restriction
- hybrid
Date in CU Experts
- January 25, 2025 2:40 AM
Full Author List
- Kirby MB; Petersen BM; Faris JG; Kells SP; Sprenger KG; Whitehead TA
author count
- 6
citation count
- 0
published in
Other Profiles
International Standard Serial Number (ISSN)
- 0027-8424
Electronic International Standard Serial Number (EISSN)
- 1091-6490
Digital Object Identifier (DOI)
Additional Document Info
volume
- 122
issue
- 4
number
- ARTN e2412787122